Stem Cell Clinics Crop Up Across The Country — But Regulation Is Almost Non-Existent
Stem cell procedures offer a lot of promise, but also carry a lot of risk. So as more clinics open, researchers are calling for additional oversight of the potentially dangerous field.
The Washington Post:
Unregulated Stem-Cell Clinics Are Proliferating Across The United States
For years, American "stem-cell tourists" have flocked to unregulated clinics in Mexico, the Caribbean and China in search of everything from heart treatments to facelifts. But now, these kinds of clinics are popping up across the United States. According to a new study, at least 351 companies with 570 clinics are marketing unapproved treatments for conditions such as osteoarthritis, Alzheimer's, autism and injured spinal cords, as well as for cosmetic enhancements. (McGinley, 6/30)
Los Angeles Times:
Hundreds Of Companies In The U.S. Are Selling Unproven Stem Cell Treatments, Study Says
From coast to coast, at least 351 businesses at 570 locations are marketing stem cell therapies that have not been fully vetted by medical researchers or blessed by the U.S. Food and Drug Administration, according to a study published Thursday in the journal Cell Stem Cell. Paul Knoepfler, a bona fide stem cell researcher at UC Davis with a doctorate in molecular pathology, and Leigh Turner, a bioethicist at the University of Minnesota who studies the ramifications of medical tourism, scoured the Internet to find companies advertising all sorts of stem cell treatments directly to patients and their families. They used nearly 100 search terms to identify as many websites as they possibly could — and turned up a lot more than they thought they would. (Kaplan, 6/30)
Kaiser Health News:
American ‘Stem Cell Tourists’ Don’t Have To Travel Abroad, Study Says
Through their searches, Turner and Knoepfler found great variation in these clinics. The treatments they offered ranged from anti-aging and other cosmetic applications to therapies for diabetes, cardiac and ophthalmological diseases as well as Parkinson’s and other degenerative conditions. Most clinics advertised stem cell treatments for orthopedic uses, followed by pain relief and sports injuries. Thirty-three clinics made marketing claims regarding muscular dystrophy and nine clinics each promoted stem cell treatments for autism and cerebral palsy, targeting parents and family members of patients. (Tan, 7/1)